Radiation Response Prediction Model Based on Integrated Clinical and Genomic Data Analysis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The value of the genomic profiling by targeted gene-sequencing on radiation therapy response prediction was evaluated through integrated analysis including clinical information. Radiation response prediction model was constructed based on the analyzed findings. Materials and methods: Patients who had the tumor sequenced using institutional cancer panel after informed consent and received radiotherapy for the measurable disease served as the target cohort. Patients with irradiated tumor locally controlled for more than 6 months after radiotherapy were defined as the durable local control (DLC) group, otherwise, non-durable local control (NDLC) group. Significant genomic factors and domain knowledge were used to develop the Bayesian Network model to predict radiotherapy response. Results: Altogether, 88 patients were collected for analysis. Of those, 41 (43.6%) and 47 (54.4%) patients were classified as the NDLC and DLC group, respectively. Somatic mutations of NOTCH2 and BCL were enriched in the NDLC group, whereas, mutations of CHEK2, MSH2, and NOTCH1 were more frequently found in the DLC group. Altered DNA repair pathway was associated with better local failure-free survival (hazard ratio, 0.40; 95% confidence interval, 0.19 to 0.86; p=0.014). Smoking somatic signature was found more frequently in the DLC group. Area under the receiver operating characteristic curve of the Bayesian network model predicting probability of 6-month local control was 0.83. Conclusion: Durable radiation response was associated with alterations of DNA repair pathway and smoking somatic signature. Bayesian network model could provide helpful insights for high precision radiotherapy. However, these findings should be verified in prospective cohort for further individualization.
Abstract
Purpose: The value of the genomic profiling by targeted gene-sequencing on radiation therapy response prediction was evaluated through integrated analysis including clinical information. Radiation response prediction model was constructed based on the analyzed findings. Materials and methods: Patients who had the tumor sequenced using institutional cancer panel after informed consent and received radiotherapy for the measurable disease served as the target cohort. Patients with irradiated tumor locally controlled for more than 6 months after radiotherapy were defined as the durable local control (DLC) group, otherwise, non-durable local control (NDLC) group. Significant genomic factors and domain knowledge were used to develop the Bayesian Network model to predict radiotherapy response. Results: Altogether, 88 patients were collected for analysis. Of those, 41 (43.6%) and 47 (54.4%) patients were classified as the NDLC and DLC group, respectively. Somatic mutations of NOTCH2 and BCL were enriched in the NDLC group, whereas, mutations of CHEK2, MSH2, and NOTCH1 were more frequently found in the DLC group. Altered DNA repair pathway was associated with better local failure-free survival (hazard ratio, 0.40; 95% confidence interval, 0.19 to 0.86; p=0.014). Smoking somatic signature was found more frequently in the DLC group. Area under the receiver operating characteristic curve of the Bayesian network model predicting probability of 6-month local control was 0.83. Conclusion: Durable radiation response was associated with alterations of DNA repair pathway and smoking somatic signature. Bayesian network model could provide helpful insights for high precision radiotherapy. However, these findings should be verified in prospective cohort for further individualization.
참고문헌 (23)
- Hyman DM, "Implementing genome-driven oncology", Cell, 168, pp.584~599 (2017)
- Zehir A, "Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10, 000 patients", Nat Med, 23, pp.703~713 (2017)
- Mateo J, "A framework to rank genomic alterations as targets for cancer precision medicine : the ESMO Scale for Clinical Actionability of molecular Targets(ESCAT)", Ann Oncol, 29, pp.1895~1902 (2018)
- Li MM, "Standards and guidelines for the interpretation and reporting of sequence variants in cancer : a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists", J Mol Diagn, 19, pp.4~23 (2017)
- Pollard JM, "Clinical radiation sensitivity with DNA repair disorders : an overview", Int J Radiat Oncol Biol Phys, 74, pp.1323~1331 (2009)
- Bergom C, "The implications of genetic testing on radiation therapy decisions : a guide for radiation oncologists", Int J Radiat Oncol Biol Phys, 105, pp.698~712 (2019)
- Forker LJ, "Biomarkers of tumour radiosensitivity and predicting benefit from radiotherapy", Clin Oncol(R Coll Radiol), 27, pp.561~569 (2015)
- Eisenhauer EA, "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)", Eur J Cancer, 45, pp.228~247 (2009)
- Suh J, "Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population", BMC Urol, 20, pp.125~ (2020)
- Park C, "Clinical application of next-generation sequencing-based panel to BRAF wild-type advanced melanoma identifies key oncogenic alterations and therapeutic strategies", Mol Cancer Ther, 19, pp.937~944 (2020)
- Li H, "Exploring single-sample SNP and INDEL calling with whole-genome de novo assembly", Bioinformatics, 28, pp.1838~1844 (2012)
- Van der Auwera GA, "From FastQ data to high confidence variant calls : the Genome Analysis Toolkit best practices pipeline", Curr Protoc Bioinformatics, 43, pp.11~ (2013)[DOI]
- Rosenthal R, "DeconstructSigs : delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution", Genome Biol, 17, pp.31~ (2016)
- Mayakonda A, "Maftools : efficient and comprehensive analysis of somatic variants in cancer", Genome Res, 28, pp.1747~1756 (2018)
- Gu Z, "circlize Implements and enhances circular visualization in R", Bioinformatics, 30, pp.2811~2812 (2014)
- DeLong ER, "Comparing the areas under two or more correlated receiver operating characteristic curves : a nonparametric approach", Biometrics, 44, pp.837~845 (1988)
- Laufer I, "The NOMS framework : approach to the treatment of spinal metastatic tumors", Oncologist, 18, pp.744~751 (2013)
- Husmeier D, "Probabilistic modeling in bioinformatics and medical informatics" (2005), Springer London
- Luo Y, "Development of a fully cross-validated Bayesian network approach for local control prediction in lung cancer", IEEE Trans Radiat Plasma Med Sci, 3, pp.232~241 (2019)
- Luo Y, "Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysis", Radiother Oncol, 123, pp.85~92 (2017)
- Ozenne B, "The precision-recall curve overcame the optimism of the receiver operating characteristic curve in rare diseases", J Clin Epidemiol, 68, pp.855~859 (2015)
- Oh JH, "A Bayesian network approach for modeling local failure in lung cancer", Phys Med Biol, 56, pp.1635~1651 (2011)
- Penson A, "Development of genome-derived tumor type prediction to inform clinical cancer care", JAMA Oncol, 6, pp.84~91 (2020)